Defining Benign/Burnt-Out MS and Discontinuing Disease-Modifying Therapies
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received July 23, 2020
- Accepted in final form December 14, 2020
- First Published February 8, 2021.
Author Disclosures
- Derek McFaul, DO (derek.j.mcfaul{at}kp.org),
- Nektar N. Hakopian, PharmD (nektar.n.hakopian{at}kp.org),
- Jessica B. Smith, MPH (jessica.b.smith{at}kp.org),
- Allen Scott Nielsen, MD (a.s.nielsen{at}kp.org) and
- Annette Langer-Gould, MD, PhD
- Derek McFaul, DO (derek.j.mcfaul{at}kp.org),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Nektar N. Hakopian, PharmD (nektar.n.hakopian{at}kp.org),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Jessica B. Smith, MPH (jessica.b.smith{at}kp.org),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Allen Scott Nielsen, MD (a.s.nielsen{at}kp.org) and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Annette Langer-Gould, MD, PhD
NONE
NONE
NONE
My husband, Michael Gould, serves as the Deputy Editor for Annals of the American Thoracic Society for the past 3 years
NONE
NONE
NONE
NONE
NONE
I am a voting panel member of California Technology Assessment Forum, a core program of the Institute for Clinical and Economic Review (ICER) and have served as expert evaluator for ICER's evaluation of MS DMTs. ICER has paid for my travel for the round table meetings.
NONE
NONE
My husband currently receives grant support from the NIH, PCORI and NCI
I received grant support from the National Institutes of Health (NIH NINDS RO1) and currently an award from PCORI (multiple PIs Piehl, Langer-Gould)
I received grant and currently have contract support from the National Multiple Sclerosis Society
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Neurology (D.M., A.L.-G.), Los Angeles Medical Center, Southern California Permanente Medical Group; Department of Drug Use Management, Los Angeles Medical Center, Kaiser Permanente (N.N.H.); Department of Research & Evaluation (J.B.S.), Southern California Permanente Medical Group, Pasadena; and Department of Neurology (A.S.N.), Fontana Medical Center, Southern California Permanente Medical Group.
- Correspondence
Dr. Langer-Gould Annette.M.Langer-Gould{at}kp.org
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. David E. Vaillancourt and Dr. Shannon Y. Chiu
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Views & Reviews
Comment on 2018 American Academy of Neurology guidelines on disease-modifying therapies in MSJohn R. Corboy, Brian G. Weinshenker, Dean M. Wingerchuk et al.Neurology, April 23, 2018 -
Review
Secondary Progressive Multiple SclerosisNew InsightsBruce A.C. Cree, Douglas L. Arnold, Jeremy Chataway et al.Neurology, June 04, 2021 -
Articles
Clinical and laboratory features of primary progressive and secondary progressive MSKhurram Bashir, John N. Whitaker et al.Neurology, September 01, 1999 -
Article
MRI activity in MS and completed pregnancyData from a tertiary academic centerMaria Houtchens, Riley Bove, Brian Healy et al.Neurology: Neuroimmunology & Neuroinflammation, September 11, 2020